Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ayako Nakashoji, M.D., Ph.D.

Concepts (82)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ayako Nakashoji's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ayako Nakashoji has written about over time.
Quinazolines, 1 publications between 2017 and 2017, average publication date October 2017. Carcinoma, Ductal, Breast, 2 publications between 2020 and 2020, average publication date August 2020. Breast Neoplasms, 7 publications between 2017 and 2023, average publication date September 2020. Genes, Homeobox, 1 publications between 2021 and 2021, average publication date January 2021. Leukemia, 1 publications between 2021 and 2021, average publication date January 2021. Ultrasonography, Mammary, 2 publications between 2020 and 2022, average publication date September 2021. Gene Expression Regulation, Neoplastic, 4 publications between 2021 and 2024, average publication date July 2023. Acrylamides, 1 publications between 2023 and 2023, average publication date November 2023. Mucin-1, 4 publications between 2023 and 2024, average publication date March 2024. Head and Neck Neoplasms, 1 publications between 2024 and 2024, average publication date May 2024. SOXB1 Transcription Factors, 1 publications between 2024 and 2024, average publication date May 2024. STAT1 Transcription Factor, 1 publications between 2024 and 2024, average publication date May 2024. Disease Progression, 3 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Nakashoji's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.